Paula Busse

Search results

• KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the AAAAI Meeting

  Busse, P.

  20/03/24

  1 item of Media coverage

  Press/Media

• KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the AAAAI Meeting

  Busse, P.

  20/03/24

  1 item of Media coverage

  Press/Media

• KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the AAAAI Meeting

  Busse, P.

  15/03/24

  1 item of Media coverage

  Press/Media

• KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the AAAAI Meeting

  Busse, P.

  14/03/24

  1 item of Media coverage

  Press/Media

• KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the AAAAI Meeting

  Busse, P.

  11/03/24

  1 item of Media coverage

  Press/Media

• KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the AAAAI Meeting

  Busse, P.

  6/03/24

  1 item of Media coverage

  Press/Media

• KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the AAAAI Meeting

  Busse, P.

  4/03/24

  1 item of Media coverage

  Press/Media

• -KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma and Immunology Annual Meeting

  Busse, P.

  28/02/24

  2 items of Media coverage

  Press/Media

• KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting

  Busse, P.

  27/02/24

  1 item of Media coverage

  Press/Media

• KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting

  Busse, P.

  27/02/24

  12 items of Media coverage

  Press/Media

• New Asthma Study Findings Have Been Reported by Researchers at Icahn School of Medicine at Mount Sinai (World Trade Center Workers With Asthma and Post-traumatic Stress Disorder Perceive Airflow Limitation More Accurately)

  Busse, P., Lin, J., Federman, A. & Weiss, J.

  15/02/24

  1 item of Media coverage

  Press/Media

• Recent Studies from University of Southern Florida Add New Data to Telemedicine (Preference for and Impact of Telehealth Vs In-person Asthma Visits Among Black and Latinx Adults)

  Busse, P.

  26/12/23

  1 item of Media coverage

  Press/Media

• EMPOWER reflects efficacy, safety of lanadelumab for HAE in real world

  Busse, P.

  7/03/22

  1 item of Media coverage

  Press/Media

• Interim Phase 4 Data Support TAKHZYRO® (lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients

  Busse, P.

  2/03/22

  1 item of Media coverage

  Press/Media

• Interim Phase 4 Data Support TAKHZYRO® (lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients

  Busse, P.

  1/03/22

  3 items of Media coverage

  Press/Media

• Interim Phase 4 Data Support TAKHZYRO® (lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients

  Busse, P.

  1/03/22

  10 items of Media coverage

  Press/Media

• Takeda Pharmaceutical Co. Ltd. (TAK) Announces Interim Phase 4 Data Support TAKHZYRO as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients

  Busse, P.

  28/02/22

  1 item of Media coverage

  Press/Media

• Takeda: Interim Phase 4 Data Support TAKHZYRO (lanadelumab) as an Effective Treatment

  Busse, P.

  28/02/22

  1 item of Media coverage

  Press/Media

• UAE - Interim Phase 4 Data Support TAKHZYRO® (lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients

  Busse, P.

  28/02/22

  1 item of Media coverage

  Press/Media

• Interim Phase 4 Data Support TAKHZYRO® (lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients

  Busse, P.

  27/02/22 → 28/02/22

  34 items of Media coverage

  Press/Media

• NIH Establishes New Childhood Asthma Clinical Research Network

  Busse, P. & Bunyavanich, S.

  30/04/21

  1 item of Media coverage

  Press/Media

• Children's National Hospital Becomes Part of the National CAUSE Clinical Research Network Under a $3 Million Grant

  Busse, P. & Bunyavanich, S.

  27/04/21

  1 item of Media coverage

  Press/Media

• NIH awards $10 million in first-year funding to establish clinical research network called CAUSE

  Busse, P. & Bunyavanich, S.

  26/04/21

  2 items of Media coverage

  Press/Media

• Children's National Hospital becomes part of the national CAUSE Clinical Research Network under a $3 million grant

  Busse, P. & Bunyavanich, S.

  26/04/21

  1 item of Media coverage

  Press/Media

• NIH awards $10 million in first-year funding to establish clinical research network called CAUSE

  Busse, P. & Bunyavanich, S.

  26/04/21

  1 item of Media coverage

  Press/Media